72.11.Z - Scientific research and development activities
10.86.Z - Production of homogenized food products and diet food
20.42.Z - Manufacture of cosmetics and toilet preparations
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.76.Z - Wholesale trade
72.19.Z - Scientific research and development activities
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -3,4 | 0,8 | -0,5 | -164,4 |
EBITDA | 1,1 | 1 | -0,3 | -126,9 |
Short time liabilities | 1,1 | 1,1 | 1 | -0,7 |
Equity capital | 9,3 | 10,1 | 9,7 | -3,6 |
Operating profit (EBIT) | 0,6 | 0,5 | -0,7 | -235,4 |
Assets | 11,4 | 12 | 12,2 | 1,4 |
Net profit (loss) | -3,3 | 0,8 | -0,4 | -146,4 |
Cash | 7,5 | 7,5 | 6,2 | -17,8 |
Liabilities and provisions for liabilities | 2,1 | 2 | 2,5 | 27,1 |
Net income from sale | 11,3 | 10,8 | 12,7 | 17,6 |
Working assets | 10,2 | 10,8 | 9,6 | -11,2 |
Depreciation | 0,5 | 0,5 | 0,5 | -4,3 |
% | % | % | p.p. | |
Profitability of capital | -35,1 | 7,8 | -3,7 | -11,5 |
Equity capital to total assets | 81,7 | 83,6 | 79,4 | -4,2 |
Gross profit margin | -29,9 | 7,4 | -4,1 | -11,5 |
EBITDA Margin | 9,7 | 9,3 | -2,1 | -11,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 35 | 35 | 30 | -5 |
Current financial liquidity indicator | 8.458126068115234 | 9.076608657836914 | 5.206139087677002 | -3,9 |
Net dept to EBITDA | -6.749595642089844 | -7.421514987945557 | 22.65968894958496 | 30,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane